EUVIMEDEUVIMED entdecken
Crossref

Strengthening nucleic acid biosecurity screening against generative protein design tools

Bruce J Wittmann iD, Tessa Alexanian iD, Craig Bartling, Jacob Beal iD, Adam Clore, James Diggans iD, Kevin Flyangolts iD, Bryan T Gemler iD, Tom Mitchell iD, Steven T Murphy iD, Nicole E Wheeler iD, Eric Horvitz iD

Science · 02.10.2025 · 390 (6768) · 82-87

DOI: 10.1126/science.adu8578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 02.10.2025. Verfasst von Bruce J Wittmann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Microsoft, Office of the Chief Scientific Officer, Redmond, WA, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Nucleic Acids, Protein Engineering, Software. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in artificial intelligence (AI)–assisted protein engineering are enabling breakthroughs in the life sciences but also introduce new biosecurity challenges. Synthesis of nucleic acids is a choke point in AI-assisted protein engineering pipelines. Thus, an important focus for efforts to enhance biosecurity given AI-enabled capabilities is bolstering methods used by nucleic acid synthesis providers to screen orders. We evaluated the ability of open-source AI-powered protein design software to create variants of proteins of concern that could evade detection by the biosecurity screening tools used by nucleic acid synthesis providers, identifying a vulnerability where AI-redesigned sequences could not be detected reliably by current tools. In response, we developed and deployed patches, greatly improving detection rates of synthetic homologs more likely to retain wild type–like function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceNucleic AcidsProtein EngineeringSoftwareBiosecurityProteins

Substanzen

Nucleic AcidsProteins

Autor:innen und Institutionen

  • Microsoft, Office of the Chief Scientific Officer, Redmond, WA, USA.
  • The International Biosecurity and Biosafety Initiative for Science (IBBIS), Geneva, Switzerland.
  • Battelle, Columbus, OH, USA.
  • RTX BBN Technologies, Cambridge, MA, USA.
  • Integrated DNA Technologies Inc., Coralville, IA, USA.
  • Twist Bioscience, South San Francisco, CA, USA.

ORCID-Profile: Bruce J Wittmann, Tessa Alexanian, Jacob Beal, James Diggans, Kevin Flyangolts, Bryan T Gemler, Tom Mitchell, Steven T Murphy, Nicole E Wheeler, Eric Horvitz

Zitieren

APA

Wittmann, B. J., Alexanian, T., Bartling, C., Beal, J., Clore, A., Diggans, J., Flyangolts, K., Gemler, B. T., Mitchell, T., Murphy, S. T., Wheeler, N. E., & Horvitz, E. (2025). Strengthening nucleic acid biosecurity screening against generative protein design tools. Science, 390(6768), 82-87. https://doi.org/10.1126/science.adu8578

Vancouver

Wittmann BJ, Alexanian T, Bartling C, Beal J, Clore A, Diggans J, et al. Strengthening nucleic acid biosecurity screening against generative protein design tools. Science. 2025;390(6768):82-87. doi:10.1126/science.adu8578

BibTeX
@article{Wittmann2025,
  author = {Wittmann, Bruce J and Alexanian, Tessa and Bartling, Craig and Beal, Jacob and Clore, Adam and Diggans, James and Flyangolts, Kevin and Gemler, Bryan T and Mitchell, Tom and Murphy, Steven T and Wheeler, Nicole E and Horvitz, Eric},
  title = {Strengthening nucleic acid biosecurity screening against generative protein design tools},
  journal = {Science},
  year = {2025},
  volume = {390},
  number = {6768},
  pages = {82--87},
  doi = {10.1126/science.adu8578}
}
Kostenlos starten →